Sae Ishimaru - Publications

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

Journal: Trials

Published: February 13, 2026

Global regulatory variability in small-molecule inhibitor approvals: Differences in timelines, dosing, and pediatric indications across FDA, EMA, and PMDA.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 01, 2025

The PedAL/EuPAL Project: A Global Initiative to Address the Unmet Medical Needs of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia.

Journal: Cancers

Published: November 20, 2023

Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trial.

Journal: International journal of clinical oncology

Published: June 17, 2023

Prevalence of pathogenic variants in cancer-predisposing genes in second cancer after childhood solid cancers.

Journal: Cancer medicine

Published: May 12, 2022

Impact of KIR-ligand mismatch on pediatric T-cell acute lymphoblastic leukemia in unrelated cord blood transplantation.

Journal: Transplantation and cellular therapy

Published: March 27, 2022

Prognostic factors of children and adolescents with T-cell acute lymphoblastic leukemia after allogeneic transplantation.

Journal: Hematological oncology

Published: December 12, 2021

NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia.

Journal: Blood advances

Published: June 11, 2021

Prognostic value of the revised International Prognostic Scoring System five-group cytogenetic abnormality classification for the outcome prediction of hematopoietic stem cell transplantation in pediatric myelodysplastic syndrome.

Journal: Bone marrow transplantation

Published: June 03, 2021

Hematopoietic stem cell transplantation for infants with high-risk KMT2A gene-rearranged acute lymphoblastic leukemia.

Journal: Blood advances

Published: December 30, 2020

Successful treatment of very severe late-onset sinusoidal obstruction syndrome with recombinant human soluble thrombomodulin, steroids, and control of intra-abdominal pressure

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 08, 2020

Nationwide study of pediatric B-cell precursor acute lymphoblastic leukemia with chromosome 8q24/MYC rearrangement in Japan.

Journal: Pediatric blood & cancer

Published: December 09, 2019